Dr. Michael Hayden is a Killam Professor of Medical Genetics at the University of British Columbia and Canada Research Chair in Human Genetics and Molecular Medicine. He is a Senior Scientist at the Center for Molecular Medicine and Therapeutics (CMMT), which he founded. He is also the founder of 5 biotech companies. Dr. Hayden is the Director of the Translational Laboratory in Genetic Medicine at the National university of Singapore and Astar. Dr. Hayden was recently named one of the 50 Canadians born in the 20th century who have changed the world.

Dr. Hayden’s work focuses on understanding the genetic roots of illness and using that understanding to develop better approaches to treatment for patients. He researches diabetes, coronary artery disease, and is part of a large collaboration to determine the genetic basis for adverse drug reactions in children. Much of his career has also been dedicated to understanding the development of Huntington disease and finding a way to cure it.